Growth Metrics

Globus Medical (GMED) Loans and Notes Receivables (2017 - 2018)

Globus Medical posted quarterly Loans and Notes Receivables of $3.3 million for Q3 2018, little changed on a QoQ basis from $3.3 million in Q2 2018.

Globus Medical (GMED) has 2 years of Loans and Notes Receivables data on file, last reported at $3.3 million in Q3 2018.

  • For the quarter ending Q3 2018, Loans and Notes Receivables changed N/A year-over-year to $3.3 million; the trailing twelve-month figure through Sep 2018 stood at $3.3 million (changed N/A YoY), and the FY2017 full-year result was $1.7 million, changed N/A from the prior year.
  • Loans and Notes Receivables for Q3 2018 stood at $3.3 million, roughly flat from $3.3 million in the prior quarter.
  • Across five years, Loans and Notes Receivables topped out at $3.3 million in Q2 2018 and bottomed at $1.7 million in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Loans & Notes Receiv. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Globus Medical 10.79 Bn 10.16 Bn 525.79 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2018 3.33 Mn
Jun 30, 2018 3.33 Mn
Mar 31, 2018 2.50 Mn
Dec 31, 2017 1.67 Mn